← Back to Search

Nicotine Replacement Therapy

AutoSense for Smoking Cessation (Time2Quit Trial)

Phase < 1
Waitlist Available
Led By Christine Vinci, Ph.D
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 36 months
Awards & highlights

Time2Quit Trial Summary

This trial looks at what happens when people try to quit smoking.

Time2Quit Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Smoking Lapse
Rate of Stress

Time2Quit Trial Design

1Treatment groups
Experimental Treatment
Group I: Smoking Cessation TherapyExperimental Treatment4 Interventions
Participants will receive 6 weeks of the nicotine patch therapy and brief counseling sessions. Participants will also receive mindfulness strategies for 10 days during both the pre- and post-quit periods via smartphone to aid in their cessation attempt. AutoSense will be worn to detect stress and lapse throughout the 10 day period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Counseling
2017
Completed Phase 4
~1970
Smartphone
2016
Completed Early Phase 1
~1740
Nicotine Patch
2011
Completed Phase 4
~10480

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
542 Previous Clinical Trials
135,442 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
378 Previous Clinical Trials
1,215,268 Total Patients Enrolled
Christine Vinci, Ph.DPrincipal InvestigatorH. Lee Moffitt Cancer Center and Research Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
JMIR Research ProtocolsJournal
Smoking Cessation Using Wearable Sensors: Protocol for a Microrandomized Trial
Hernandez, Laura M, David W Wetter, Santosh Kumar, Steven K Sutton, and Christine Vinci. 2021. “Smoking Cessation Using Wearable Sensors: Protocol for a Microrandomized Trial”. JMIR Research Protocols. JMIR Publications Inc.. doi:10.2196/22877.
clinicaltrials.govStudy
Applying mHealth to Tobacco-related Health Disparities
2018. "Applying mHealth to Tobacco-related Health Disparities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03404596.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top